KaloBios Pharmctcls (KBIO): Shkreli, Tin Foil Hat Firmly On, Ousted

The embattled Martin Shkreli, who recently found himself facing seven counts of securities fraud and watched almost half the value of his bio-tech empire disappear, was dislodged from his position as CEO of KaloBios Pharmaceuticals Monday. With the last fingernail Shkreli had embedded into the world he once managed removed, the former CEO of Turing Pharmaceuticals decided to take what might be an ill-advised swing at the U.S. Justice system, pointing to social media as a real reason for his arrest.   With its stock trading halted, KaloBios ends its relationship with Shkreli on difficult terms KaloBios is a “microcap”…